SCHEMBL18487538

SCHEMBL18487538

C#CCOc1ccc2c3ccc(OC)cc3n(CC=C)c2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.48
DYRK1A Q13627 8/20 0.42
MAOA P21397 1/20 0.40
DYRK3 O43781 1/20 0.40
CLK1 P49759 1/20 0.40
CLK2 P49760 1/20 0.40
CLK3 P49761 1/20 0.40
GSK3B P49841 1/20 0.40
DYRK2 Q92630 1/20 0.40
CLK4 Q9HAZ1 1/20 0.40
DYRK4 Q9NR20 1/20 0.40
DYRK1B Q9Y463 1/20 0.40
L3MBTL1 Q9Y468 2/20 0.39
HCRTR1 O43613 1/20 0.39
ATM Q13315 1/20 0.39
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 2/20 0.39
TSHR P16473 2/20 0.39
GLA P06280 1/20 0.39
GAA P10253 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18487332 0.84 DYRK1A (0.45) ACHEDYRK1AMAOADYRK3CLK1
SCHEMBL18487541 0.84 ACHE (0.62) ACHEDYRK1AMAOADYRK3CLK1
SCHEMBL20438859 0.82 KDM4E (0.44) ACHEDYRK1AMAOADYRK3CLK1
SCHEMBL20800900 0.80 ACHE (0.57) ACHEDYRK1AMAOADYRK3CLK1
SCHEMBL23150420 0.72 DYRK1A (0.73) ACHEDYRK1AMAOAHASPINHTR2A
SCHEMBL2794137 0.71 TNFRSF1A (0.46) DYRK1AL3MBTL1HCRTR1ATMKDM4E
SCHEMBL18487312 0.71 DYRK1A (0.48) ACHEDYRK1AMAOADYRK3CLK1
SCHEMBL20434642 0.70 MAPT (0.41) ACHEDYRK1AL3MBTL1HCRTR1ATM
SCHEMBL2792990 0.70 TNFRSF1A (0.43) DYRK1AL3MBTL1HCRTR1ATMKDM4E
SCHEMBL791878 0.69 MAOB (0.54) MAOATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017023916-A1 SMALL MOLECULE ANDROGEN RECEPTOR INHIBITORS AND METHODS OF USE THEREOF GEORGETOWN UNIVERSITY (US) 2017-02-09 WO disclosed